Friday, May 27, 2016

Pharma: Valeant says NO to joint Takeda and TPG takeover

...giving Papa time to run the ship as the newly appointed chief executive.  So, the Quebec keeps the embattled but said to be world-class franchise known for therapeutic areas with dynamic workforce and affordable products...
The rejection came after a "premium" offer in a time when Valeant stocks had been plunging this year - perhaps due to debt load scandal and prompting to sell off non-core assets.  Valeant won a bid over Takeda last year of Salix which Valeant predictors think it's could be worth $1B in sales this year.  Upon news, VRX traded +6% to $28.  For Takeda, the takeover would have provided a spark to Xifaxan and uplift to Entyvio - reportedly.
Read more on Wall Street Journal
on

2 comments:

  1. AnonymousAugust 1, 2025 at 9:15 AM

    EC7A637F84
    kiralık hacker
    hacker arıyorum
    kiralık hacker
    hacker arıyorum
    belek

    ReplyDelete
  2. AnonymousFebruary 15, 2026 at 12:01 AM

    8BD1484B78
    Many online platforms offer a variety of resources for digital artists and creators, helping them enhance their skills and showcase their work. These sites often include tutorials, community forums, and downloadable assets to support artistic growth. For those seeking a comprehensive hub, [1] provides valuable tools and insights tailored to digital art enthusiasts. Utilizing such platforms can significantly improve one's creative process and connect artists globally.

    ReplyDelete

Subscribe to: Post Comments (Atom)